Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
CompletedNCT05245669
Enzene Biosciences Ltd.Healthy Male Subjects
Start: 2022-01-10End: 2024-05-22Updated: 2025-12-23